Algicid JR Oral Suspension

Gastric reflux, heartburn, flatulence associated with gastric reflux, heartburn of pregnancy, all cases of
epigastric and retrosternal distress where the underlying cause is gastric reflux.

On ingestion the product reacts rapidly with gastric acid to form a raft of alginic acid gel having a near neutral pH and which floats on the stomach contents, quickly and effectively impeding gastrooesophageal reflux, for up to 4 hours. In severe cases the raft itself may be refluxed into the esophagus, in preference to the stomach contents, and exert a demulcent effect.

Indicated for children of 1-2 years. Consult with a registered physician for use in children below 1 year or
above 2 years.

Less than 4.5 kg body weight: 1 sachet maximum 6 times daily

More than 4.5 kg body weight: 2 sachets maximum 6 times daily

Bottle feed infants: Mix each sachet into 115 ml (4 fl oz) of feed in the bottle. Shake well and feed as normal.

Breast feed infants and other infants up to 2 years: Mix each sachet with 5 ml (1 teaspoon) of cooled boiled water until a smooth paste is formed. Add another 10 ml (2 teaspoons) of cooled boiled water and mix. For breast feed infants give Gaviscon Infant part way through each feed or meal using a spoon or feeding bottle. For all other infants give Gaviscon Infant at the end of each meal using a spoon, or feeding bottle.

Treatment should not be administered more than six times in any 24 hour period. Not suitable for children over 2 years of age, adults or the elderly.

A time-interval of 2 hours should be considered between Algicid intake and the administration of other medicinal products, especially tetracyclines, digoxine, fluoroquinolone, iron salt, ketoconazole, neuroleptics, thyroid hormones, penicillamine, beta-blockers (atenolol, metoprolol, propanolol), glucocorticoid, chloroquine, biphosphonates and estramustine.

This is contraindicated in patients with known or suspected hypersensitivity to the active substances or to
any of the excipients including methyl parahydroxybenzoate and propyl parahydroxybenzoate.

Clinical studies in more than 281 pregnant women as well as a large amount of data from post marketing experience indicate no malformative nor feto/ neonatal toxicity of the active substances. Algicid can be used during pregnancy, if clinically needed. No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. Algicid can be used during breast-feeding.

If symptoms do not improve after seven days, the clinical situation should be reviewed. This medicinal product contains 255.76 mg (11.12 mmol) sodium per 20 ml dose, equivalent to 12.79 % of the WHO recommended maximum daily intake for Sodium. The maximum daily dose of Algicid JR is equivalent to 51.15% of the WHO recommended maximum daily intake for Sodium. Each 20 ml contains 260 mg (6.5 mmol) of Calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent Calcium containing renal calculi.

Over dosage with this formulation is a rare case. In case of overdose please consult with a registered physician.

Antacids

Do not store above 30⁰C. Keep away from light and out of the reach of children.